Autophagy-related genes affect the survival of multiple myeloma patients depending on chromosomal abnormality

Ayna Duran, Gizem; Benderli Cihan, Yasemin

doi:10.2478/abm-2022-0028

Abstract

Background

Targeting autophagy at gene level may be promising in multiple myeloma (MM) treatment depending on chromosomal abnormality (ABN) status.

Objectives

We aimed to investigate the role of ABN on survival of MM patients and to identify prognosis related autophagy-related genes (ARGs) for patients with or without ABN.

Methods

Gene intensity values of 222 ARG for 548 MM patients were obtained from the Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) platform containing 54,675 probes (GSE24080). A dataset containing data from 1576 MM patients with 1q21 amplification (GSE4204, GSE4452, GSE4581, and GSE2658) was used for validation. Survival analysis of the patients was analyzed using univariate and multivariate Cox regression method with the help of R3.53 programming language and Kaplan–Meier graphics were created. The Gene Ontology enRIchmentanaLysis and visuaLizAtion (GOrilla) tool was used to define the related biological processes and pathways.

Results

The overall survival (OS) and event-free survival (EFS) in all MM patients were strongly influenced by ABN. In the group of patients with ABN, 41 ARGs were found to be important in prognosis, whereas in the group of patients without ABN, 13 ARGs were found to be important in prognosis. CDKN1A, FKBP1B, FOXO3, and NCKAP1 ARGs were commonly significant in both groups and found to be survival triggering.

Conclusions

The classification of MM patients according to the absence or presence of ABN is important in the determination of survival status. Detection of survival related ARGs in patients with chromosomal anomalies may be a new therapeutic target in treatment.

References

Mizushima N. Autophagy: process and function. Genes Dev. 2007; 21:2861–73.
Search in Google Scholar Back to article
Knaevelsrud H, Ahlquist T, Merok MA, Nesbakken A, Stenmark H, Lothe RA, Simonsen A. UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy. Autophagy. 2010; 6:863–70.
Search in Google Scholar Back to article
Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011; 17:654–66.
Search in Google Scholar Back to article
Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132:27–42.
Search in Google Scholar Back to article
Lorin S, Hamaï A, Mehrpour M, Codogno P. Autophagy regulation and its role in cancer. Semin Cancer Biol. 2013; 23:361–7.
Search in Google Scholar Back to article
White E, Karp C, Strohecker AM, Guo Y, Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol. 2010; 22:212–7.
Search in Google Scholar Back to article
Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007; 21:1367–81.
Search in Google Scholar Back to article
Saha S, Panigrahi DP, Patil S, Bhutia SK. Autophagy in health and disease: a comprehensive review. Biomed Pharmacother. 2018; 104:485–95.
Search in Google Scholar Back to article
Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Kim SS, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009; 217:702–6.
Search in Google Scholar Back to article
Lu D, Yang C, Zhang Z, Cong Y, Xiao M. Knockdown of linc00515 inhibits multiple myeloma autophagy and chemoresistance by upregulating miR-140-5p and downregulating ATG14. Cell Physiol Biochem. 2018; 48:2517–27.
Search in Google Scholar Back to article
MAQC Consortium. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol. 2010; 28:827–38.
Search in Google Scholar Back to article
Usmani SZ, Sexton R, Hoering A, Heuck CJ, Nair B, Waheed S, et al. Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance. Blood. 2012; 120:1597–600.
Search in Google Scholar Back to article
Nahi H, Sutlu T, Jansson M, Alici E, Gahrton G. Clinical impact of chromosomal aberrations in multiple myeloma. J Intern Med. 2011; 269:137–47.
Search in Google Scholar Back to article
Avet-Loiseau H, Li C, Magrangeas F, Gouraud W, Charbonnel C, Harousseau JL, et al. Prognostic significance of copy-number alterations in multiple myeloma. J Clin Oncol. 2009; 27:4585–90.
Search in Google Scholar Back to article
Van Wier S, Braggio E, Baker A, Ahmann G, Levy J, Carpten JD, Fonseca R. Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma. Haematologica. 2013; 98:1586–92.
Search in Google Scholar Back to article
Zhang Y, Chen XL, Chen WM, Zhou HB. Prognostic nomogram for the overall survival of patients with newly diagnosed multiple myeloma. Biomed Res Int. 2019; 8:5652935. doi: 10.1155/2019/5652935
Open DOI Search in Google Scholar Back to article
Kumar S, Fonseca R, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 2012; 119:2100–5.
Search in Google Scholar Back to article
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017; 67:93–9.
Search in Google Scholar Back to article
Zhang BH, Yang J, Jiang L, Lyu T, Kong LX, Tan YF, et al. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma. Genomics. 2020; 112:2763–71. doi: 10.1016/j.ygeno.2020.03.013
Open DOI Search in Google Scholar Back to article
Hu D, Jiang L, Luo S, Zhao X, Hu H, Zhao G, Tang W. Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients. J Transl Med. 2020; 18:160. doi: 10.1186/s12967-020-02323-x
Open DOI Search in Google Scholar Back to article
Lin P, He RQ, Dang YW, Wen DY, Ma J, He Y, et al. An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients. Oncotarget. 2018; 9:17368–95.
Search in Google Scholar Back to article
Huang Z, Liu J, Luo L, Sheng P, Wang B, Zhang J, Peng SS. Genome-wide identification of a novel autophagy-related signature for colorectal cancer. Dose Response. 2019; 17:1559325819894179. doi: 10.1177/1559325819894179
Open DOI Search in Google Scholar Back to article
Lin QG, Liu W, Mo YZ, Han J, Guo ZX, Zheng W, et al. Development of prognostic index based on autophagy-related genes analysis in breast cancer. Aging (Albany NY). 2020; 12:1366–76.
Search in Google Scholar Back to article
Zhu FX, Wang XT, Zeng HQ, Yin ZH, Ye ZZ. A predicted risk score based on the expression of 16 autophagy-related genes for multiple myeloma survival. Oncol Lett. 2019; 18:5310–24.
Search in Google Scholar Back to article
McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep. 2012; 13:528–38.
Search in Google Scholar Back to article
Bakhoum SF, Cantley LC. The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell. 2018; 174:1347–60.
Search in Google Scholar Back to article
Engelhardt M, Terpos E, Kleber M, Gay F, Wäsch R, Morgan G, et al. European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica. 2014; 99:232–42.
Search in Google Scholar Back to article
Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015; 33:2863–9.
Search in Google Scholar Back to article
Neben K, Jauch A, Bertsch U, Heiss C, Hielscher T, Seckinger A, et al. Combining information regarding chromosomal aberrations t(4;14) and del(17pl3) with the international staging system classification allows stratification of myeloma patients undergoing autologous stem cell transplantation. Haematologica. 2010; 95:1150–7.
Search in Google Scholar Back to article
Kalff A, Spencer A. The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies. Blood Cancer J. 2012; 2:e89. doi: 10.1038/bcj.2012.37
Open DOI Search in Google Scholar Back to article
Mei H, Xiang Y, Mei H, Fang B, Wang Q, Cao D, et al. Pterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells. Int J Mol Med. 2018; 42:2676–88.
Search in Google Scholar Back to article
Desantis V, Saltarella I, Lamanuzzi A, Mariggiò MA, Racanelli V, Vacca A, Frassanito MA. Autophagy: a new mechanism of prosurvival and drug resistance in multiple myeloma. Transl Oncol. 2018; 11:1350–7.
Search in Google Scholar Back to article
Rozental A, Gafter-Gvili A, Vidal L, Raanani P, Gurion R. The role of maintenance therapy in patients with diffuse large B cell lymphoma: a systematic review and meta-analysis. Hematol Oncol. 2019; 37:27–34.
Search in Google Scholar Back to article
Ayna G, Krysko DV, Kaczmarek A, Petrovski G, Vandenabeele P, Fésüs L. ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS One. 2012; 7:e40069. doi: 10.1371/journal.pone.0040069
Open DOI Search in Google Scholar Back to article
Lamy L, Ngo VN, Emre NC, Shaffer AL 3rd, Yang Y, Tian E, et al. Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell. 2013; 23:435–49.
Search in Google Scholar Back to article
Pullarkat V, Meng Z, Donohue C, Yamamoto VN, Tomassetti S, Bhatia R, et al. Iron chelators induce autophagic cell death in multiple myeloma cells. Leuk Res. 2014; 38:988–96.
Search in Google Scholar Back to article
Petrovski G, Ayna G, Majai G, Hodrea J, Benko S, Mádi A, Fésüs L. Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages. Autophagy. 2011; 7:321–30.
Search in Google Scholar Back to article